Wells Fargo & Company Applied Molecular Transport Inc. Transaction History

Wells Fargo & Company

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.16 - $0.34 $2,576 - $5,474	-16,101 Reduced 99.25%	121 $0
Q2 2023 Aug 15, 2023	BUY	$0.24 - $0.37 $1 - $2	6 Added 0.04%	16,222 $4,000
Q1 2023 May 12, 2023	BUY	$0.32 - $0.68 $0 - $1	2 Added 0.01%	16,216 $5,000
Q4 2022 Feb 13, 2023	BUY	$0.35 - $1.26 $1 - $3	3 Added 0.02%	16,214 $6,000
Q3 2022 Nov 14, 2022	BUY	$1.12 - $3.12 $2 - $6	2 Added 0.01%	16,211 $16,000
Q2 2022 Aug 12, 2022	SELL	$2.76 - $7.65 $14,812 - $41,057	-5,367 Reduced 24.87%	16,209 $47,000
Q1 2022 May 16, 2022	BUY	$5.63 - $13.88 $60,432 - $148,987	10,734 Added 99.0%	21,576 $162,000
Q4 2021 Feb 14, 2022	BUY	$13.23 - $26.05 $143,307 - $282,173	10,832 Added 108320.0%	10,842 $151,000
Q3 2021 Nov 15, 2021	SELL	$25.87 - $46.61 $1,810 - $3,262	-70 Reduced 87.5%	10 $0
Q2 2021 Aug 16, 2021	SELL	$39.76 - $64.31 $125,681 - $203,283	-3,161 Reduced 97.53%	80 $3,000
Q1 2021 May 13, 2021	SELL	$30.5 - $74.14 $149,419 - $363,211	-4,899 Reduced 60.18%	3,241 $143,000
Q4 2020 Feb 09, 2021	SELL	$29.39 - $35.0 $37,942 - $45,185	-1,291 Reduced 13.69%	8,140 $250,000
Q3 2020 Nov 05, 2020	BUY	$20.49 - $33.58 $193,241 - $316,692	9,431 New	9,431 $300,000

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.